Taprizosin
Taprizosin (UK-338003) is an orally bioavailable, selective α1-adrenoceptor antagonist used in research for benign prostatic hyperplasia. It facilitates vasodilation and is employed in both in vitro binding assays and in vivo models to study urinary tract smooth muscle relaxation.
Product Specifications
CAS Number
210538-44-6
Product Name Alternative
Adrenergic Receptor, AdrenergicReceptor, UK 338003, UK-338,003, UK338003, UK-338003, α1-adrenergic receptor, Taprizosin, Taprizosin Mesylate
Field of Research
Neuroscience, Pharmacology & Drug Discovery
Purity
96.34% (May vary between batches)
Solubility
DMSO:60 mg/mL (118.44 mM)
Smiles
NC=1C=2C (=C (OC) C (OC) =CC2N=C (N1) N3CC=4C (CC3) =C (NS (C) (=O) =O) C=CC4) C5=CC=CC=N5
Molecular Formula
C25H26N6O4S
Molecular Weight
506.58
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
LV757834 1.0 µg DNA
ATP6V1E1P3 Lentiviral Vector (Human) (EF1a) (pLenti-GIII-EF1a)
Sign In for Pricing
View Details 
ARP69409_P050 100 µL
C8orf42 Antibody - N-terminal region (ARP69409_P050)
Sign In for Pricing
View Details